A single arm clinical study to evaluate the antipyretic effect Of Febrikid Suspension in Febrile Children.

Department of Kaumarbhritya0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•1. Patient of either gender suffering from fever of age 3-10 years.
•2. Acute onset of fever of 1 to 3 days.
•3. Temperature between 99-102 Fahrenheit.
•4. Children with parents who agree to participate and sign the informed consent.

•1. Fever more than 102 Fahrenheit.
•2. Chronic fever associated with infective disorder.
•3. Fever more than 3 days and diagnosed with malaria, dengue, typhoid, pneumonia etc.
•4. Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator as non induceable will be excluded from study.

发起方

Department of Kaumarbhritya